These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 16231757)
1. The Japanese Trial to Assess Optimal Systolic Blood Pressure in Elderly Hypertensive Patients (JATOS): protocol, patient characteristics, and blood pressure during the first 12 months. JATOS Study Group Hypertens Res; 2005 Jun; 28(6):513-20. PubMed ID: 16231757 [TBL] [Abstract][Full Text] [Related]
2. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). JATOS Study Group Hypertens Res; 2008 Dec; 31(12):2115-27. PubMed ID: 19139601 [TBL] [Abstract][Full Text] [Related]
3. Comparison of strict- and mild-blood pressure control in elderly hypertensive patients: a per-protocol analysis of JATOS. Rakugi H; Ogihara T; Goto Y; Ishii M; Hypertens Res; 2010 Nov; 33(11):1124-8. PubMed ID: 20686490 [TBL] [Abstract][Full Text] [Related]
4. Impact of renal function on cardiovascular events in elderly hypertensive patients treated with efonidipine. Hayashi K; Saruta T; Goto Y; Ishii M; Hypertens Res; 2010 Nov; 33(11):1211-20. PubMed ID: 20844543 [TBL] [Abstract][Full Text] [Related]
5. No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial. Kjeldsen SE; Berge E; Bangalore S; Messerli FH; Mancia G; Holzhauer B; Hua TA; Zappe D; Zanchetti A; Weber MA; Julius S Blood Press; 2016; 25(2):83-92. PubMed ID: 26511535 [TBL] [Abstract][Full Text] [Related]
6. Treatment of Hypertension: Which Goal for Which Patient? Jarraya F Adv Exp Med Biol; 2017; 956():117-127. PubMed ID: 27722961 [TBL] [Abstract][Full Text] [Related]
7. The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients. Liu L; Zhang Y; Liu G; Li W; Zhang X; Zanchetti A; J Hypertens; 2005 Dec; 23(12):2157-72. PubMed ID: 16269957 [TBL] [Abstract][Full Text] [Related]
8. Association of blood pressure control and metabolic syndrome with cardiovascular risk in elderly Japanese: JATOS study. Kawano Y; Ogihara T; Saruta T; Goto Y; Ishii M Am J Hypertens; 2011 Nov; 24(11):1250-6. PubMed ID: 21814293 [TBL] [Abstract][Full Text] [Related]
9. Impact of blood pressure control on cardiovascular events in 26,512 Japanese hypertensive patients: the Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study, a prospective nationwide observational study. Shimamoto K; Fujita T; Ito S; Naritomi H; Ogihara T; Shimada K; Tanaka H; Yoshiike N; Hypertens Res; 2008 Mar; 31(3):469-78. PubMed ID: 18497466 [TBL] [Abstract][Full Text] [Related]
11. Effect of antihypertensive treatment on cardiovascular events in elderly hypertensive patients: Japan's Benidipine Research on Antihypertensive Effects in the Elderly (J-BRAVE). Saito I; Suzuki H; Kageyama S; Saruta T Clin Exp Hypertens; 2011; 33(2):133-40. PubMed ID: 21269056 [TBL] [Abstract][Full Text] [Related]
12. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. Lithell H; Hansson L; Skoog I; Elmfeldt D; Hofman A; Olofsson B; Trenkwalder P; Zanchetti A; J Hypertens; 2003 May; 21(5):875-86. PubMed ID: 12714861 [TBL] [Abstract][Full Text] [Related]
13. Dihydropyridine calcium-channel blockers for antihypertensive treatment in older patients--evidence from the Systolic Hypertension in Europe Trial. Staessen JA; Thijs L; Celis H; Gasowski J; Wang JG; Fagard RH; S Afr Med J; 2001 Dec; 91(12):1060-8. PubMed ID: 11845604 [TBL] [Abstract][Full Text] [Related]
14. Treatment of hypertension in patients 85 years of age or older: a J-BRAVE substudy. Saito I; Suzuki H; Kageyama S; Saruta T Clin Exp Hypertens; 2011; 33(5):275-80. PubMed ID: 21787236 [TBL] [Abstract][Full Text] [Related]
15. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study. Shimada K; Ogihara T; Saruta T; Kuramoto K; Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495 [TBL] [Abstract][Full Text] [Related]
16. Hypertension in the Very Elderly Trial (HYVET): protocol for the main trial. Bulpitt C; Fletcher A; Beckett N; Coope J; Gil-Extremera B; Forette F; Nachev C; Potter J; Sever P; Staessen J; Swift C; Tuomilehto J Drugs Aging; 2001; 18(3):151-64. PubMed ID: 11302283 [TBL] [Abstract][Full Text] [Related]
17. Achieving blood pressure control targets in hypertensive patients of rural China - a pilot randomized trial. Huang X; Liu L; Song Y; Gao L; Zhao M; Bao H; Qin X; Wu Y; Wu Q; Bi C; Yue A; Fang C; Ma H; Cui Y; Tang G; Li P; Zhang Y; Li J; Wang B; Xu X; Wang H; Parati G; Spence JD; Wang X; Huo Y; Chen G; Cheng X; Trials; 2020 Jun; 21(1):515. PubMed ID: 32527283 [TBL] [Abstract][Full Text] [Related]
18. Anti-hypertensive effect of manidipine: 24 hours monitoring evaluation and Doppler-echocardiographic remarks. Celentano A; Crivaro M; Perticone F; Palmieri V; Oliviero M; Tammaro P; Pietropaolo I; Di Palma Esposito N; Cloro C; Cosco C; Mattioli PL; De Divitiis O Blood Press Suppl; 1996; 5():29-35. PubMed ID: 8973790 [TBL] [Abstract][Full Text] [Related]
19. Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial. Mancia G; Kjeldsen SE; Zappe DH; Holzhauer B; Hua TA; Zanchetti A; Julius S; Weber MA Eur Heart J; 2016 Mar; 37(12):955-64. PubMed ID: 26590384 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of manidipine hydrochloride in the long-term treatment of mild-moderate hypertension. Manidipine Efficacy in Long-Term Treatment Group. Fogari R; Zoppi A; Lusardi P; Mugellini A Blood Press Suppl; 1996; 5():24-8. PubMed ID: 8973789 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]